As the thread-creator wrote:
That is the point of Congressional hearings for members such as Katie Porter–that is, for the members who actually want to accomplish something for their constituents. And that something they are accomplishing is not “berating” business executives or promoting any particular characterization of business executives (as “baddies” or anything else).
The point of Porter’s questioning in hearings is to communicate to the American people.
And that is important because legislation to improve matters can happen only if voters support it, and they won’t support it if they don’t understand or even see the problem. The particular problem under discussion in this thread is that for decades, now, the pharmaceutical industry has successfully communicated a lie: namely, that they should not be subjected to regulation (or taxes!) because of the supposedly-massive amounts they are spending on Research and Development.
And as Porter’s questioning revealed, actual spending on R&D is far less important to this company, AbbVie, than AbbVie would like voters to believe.
Porter, in this and other hearings, is exposing the lies that have permitted the status quo to chug along for so many years, transferring wealth from ordinary Americans to the top 1% in a way that has made our nation less secure and less productive. (And note that she does so with specifics–with checkable facts–not with generalizations or “grandstanding”.)